Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 14, 2019
June 20, 2024
3c6c8653-5a0c-4cb1-b776-530e73843765
Related Documents
Referencing Approved Drug Products in ANDA Submissions Guidance for Industry
Guidance DocumentOctober 27, 2020Center for Drug Evaluation and Research
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
Guidance DocumentApril 28, 2015Center for Drug Evaluation and Research
Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
Guidance DocumentDecember 2, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox